Coronavirus update | Interpreting recovery rates, and controversy over a study about HCQ | The Hindu In Focus Podcast

We take a look at India’s recovery rate, which is close to crossing 50%, and analyse why that number is important and what it shows about how the disease is affecting the population even as each new day seems to bring a new 24-hour high in cases recorded.

Hydroxychloroquine is also back in the news after a study, published in the reputed journal Lancet about its adverse side-effects, reportedly used data supplied by a dubious U.S.-based data analytics company called Surgisphere. We discuss the potential ramifications.

Guest: Jacob Koshy, Deputy Science Editor, The Hindu.

Find the In Focus podcast on Spotify, Apple Podcasts and Stitcher. Search for In Focus by The Hindu.

Write to us with comments and feedback at socmed4@thehindu.co.in

Printable version | Jul 8, 2020 10:18:13 AM | https://www.thehindu.com/podcast/coronavirus-update-interpreting-recovery-rates-and-controversy-over-a-study-about-hcq-the-hindu-in-focus-podcast/article31743696.ece

Next Story